KP Tissue Inc. (TSE:KPT - Free Report) - Analysts at Desjardins boosted their Q2 2025 earnings per share estimates for KP Tissue in a research report issued on Wednesday, May 14th. Desjardins analyst F. Tremblay now expects that the company will post earnings of $0.16 per share for the quarter, up from their previous forecast of $0.07. Desjardins currently has a "Hold" rating and a $8.50 target price on the stock. The consensus estimate for KP Tissue's current full-year earnings is $0.44 per share. Desjardins also issued estimates for KP Tissue's FY2025 earnings at $0.64 EPS.
Separately, TD Securities reduced their target price on KP Tissue from C$8.50 to C$8.00 and set a "hold" rating on the stock in a report on Thursday, April 17th.
Read Our Latest Stock Analysis on KP Tissue
KP Tissue Stock Up 1.9%
Shares of KP Tissue stock opened at C$8.79 on Monday. KP Tissue has a 52 week low of C$7.54 and a 52 week high of C$8.80. The stock's 50-day simple moving average is C$8.05 and its 200-day simple moving average is C$8.09. The company has a market capitalization of C$87.85 million, a price-to-earnings ratio of 13.76, a PEG ratio of -0.88 and a beta of 0.37.
KP Tissue Company Profile
(
Get Free Report)
KP Tissue Inc, through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through two segments, Consumer and Away-From-Home. It offers bathroom and facial tissues, paper towels, and napkins.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider KP Tissue, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KP Tissue wasn't on the list.
While KP Tissue currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
